Clinical trial
Escitalopram in Bipolar Depression: a Placebo-controlled Study of Acute and…
NCT00464191 · Nordfjord Psychiatric Centre, Other · Terminated
Key facts
| NCT number | NCT00464191 |
|---|---|
| Title | Escitalopram in Bipolar Depression: a Placebo-controlled Study of Acute and Maintenance Treatment |
| Official title | Escitalopram in Bipolar Depression: a Placebo-controlled Study of Acute and Maintenance Treatment |
| Lead sponsor | Nordfjord Psychiatric Centre, Other |
| Collaborators | H. Lundbeck A/S Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | escitalopram |
| Enrollment | 150 |
| Start date | Apr 1, 2006 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Apr 23, 2007 |
| Last update posted | Sep 21, 2009 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: